Skip to content

Type-2 diabetes mellitus and homoeopathy medicines of indian plant origin

Role of Predefined Homoeopathic Medicine of Indian Plant Origin in the Manegment of Type-2 Diabetes Mellitus:An Open label Single arm Interventional Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/096975
Enrollment
32
Registered
2025-11-06
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Predefined Homoeoapthic Medicine of Indian Plant origin: After enrolment an in-depth and thorough case taking will be done for each of the patient. Case taking will be followed by analy
dosage and repetition depending upon the individual requirement of the case. All medicines will be procured from a Good Manufacturing practice (GMP) certified firm. Total duration of intervention 3 mo

Sponsors

DrAditya Narayan Puilya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with Type-2-diabetes mellitus without complication 2.Diagnostic criteria – FBS-126 to 150mg/dl. PPBS – 200 to 300 mg/dl. HBA1C More then 7. 3. Patient not taking any anti diabetic medication since last 6 weeks from any system of medicine. 4.Providing written informed consent to participate in the study. 5.Patients of 18-60 years of age, both sexes.

Exclusion criteria

Exclusion criteria: 1.Patients suffering from both the macro and microvascular complications of diabetes mellitus. 2.Patients having major life-threatening disorder. 3.Other uncontrolled or unstable systemic or psychiatric diseases and/or infections affecting quality of life. 4.Patients who are too sick for consultation. 5.Pregnant and puerperal women, and lactating mothers. 6.Substance abuse and/or dependence. 7.immune-compromised state. 8.Undergoing homoeopathic treatment for any chronic disease within the last 6 months.

Design outcomes

Primary

MeasureTime frame
It will be measured through assessment of level of glucose in venous blood in fasting state or 2 hours after the intake of a 75g glucose meal. Scoring and Interpretation- Diabetes is confirmed by international consensus as, Plasma glucose in a random sample or 2 hrs after a 75 g glucose load is more than 200 mg per dl or Fasting plasma glucose is more than 126 mg per dl, or, HBA1C is more than 7 Timepoint: At Baseline, upto 3 months

Secondary

MeasureTime frame
Audit of Diabetes Dependent Quality Timepoint: At Baseline, upto 3 months

Countries

India

Contacts

Public ContactDrRupali Bhaduri

The Calcutta Homoeopathic Medical College and Hospital

drrupalibhaduri@gmail.com8370858625

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026